The Lamkin Clinic

The Lamkin Clinic The Lamkin Clinic is an anti-aging, functional, and precision medicine practice in Edmond, Oklahoma. Telemedicine appointments are available. Learn More.

Dr. Brian & Deb Lamkin - Est. 2007
💕 Your health journey partners
🌱 Longevity • Hormones • Peptides • Etc
📍 Oklahoma + Virtual everywhere
✨ Functional medicine for real results
👇 Let's start together Opened in 2007 by Brian Lamkin, DO, the practice takes a unique approach to health and wellness, providing therapies that promote proactive-preventive medical care. The Lamkin Clinic keeps its focus o

n patients, not merely treating diseases, and specializes in managing conditions like allergies and asthma, arthritis, autoimmune disease, and diabetes. The wellness clinic offers a wide variety of treatment options, specialty services, and health products so they can provide an integrative plan for all patients. This includes functional and nutritional medicine and programs, male and female bioidentical hormone evaluations, and medical weight loss management. For holistic, proactive, preventive care, call The Lamkin Clinic, or schedule an appointment online today.

08/25/2026

Two patients present with identical body weight. One has 36% body fat and significantly reduced lean mass. One has 19% body fat with strong skeletal muscle and healthy bone density. The scale told you nothing useful about the difference between them.

A DEXA scan tells you everything.

DEXA (dual-energy X-ray absorptiometry) is the clinical gold standard for body composition analysis. It provides a precise breakdown of fat mass, lean mass, and bone mineral density by region. It generates a visceral adipose tissue measurement, the metabolically active fat surrounding the organs that drives insulin resistance, cardiovascular risk, and inflammatory load. It gives a fat-to-lean ratio that shows whether weight lost during a protocol actually represents fat loss, or whether muscle is being sacrificed in the process.

This matters in four specific clinical contexts we see regularly at The Lamkin Clinic. For patients beginning a medical weight loss protocol, especially GLP-1 therapy, a baseline DEXA before starting and follow-up scans at intervals track whether lean mass is being protected. For patients with normal BMI but elevated cardiovascular risk, DEXA may reveal visceral fat burden the scale completely obscures. For postmenopausal women, bone density screening is integrated into the same scan, combining osteoporosis evaluation with body composition analysis in one appointment. For patients on testosterone or hormone replacement therapy, DEXA tracks body composition response alongside hormonal labs.

The number on the scale is not the outcome we manage. Body composition is.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma
lamkinclinic.com

08/24/2026

The thymus is a small organ most people have never considered. It sits behind the breastbone and, in childhood and early adulthood, produces the naive T cells that anchor the immune system's ability to recognize and respond to new threats.

Starting in your twenties, it begins to shrink. By your sixties, it has lost roughly 75 percent of its functional mass. The result is a condition researchers call immunosenescence, the gradual, measurable decline of immune function that is now understood to be a significant driver of biological aging.

The practical consequences are real and underappreciated. An immune system that produces fewer naive T cells becomes increasingly reliant on aging memory T cells that respond less efficiently and more erratically. Defense against new infections weakens. Surveillance against cancerous and precancerous cells becomes less reliable. Inflammatory signaling increases as immune regulation deteriorates. This is one of the key biological mechanisms behind what researchers call inflammaging, the low-grade chronic inflammation that underlies cardiovascular disease, cognitive decline, metabolic dysfunction, and accelerated tissue aging.

There is currently no standard clinical test for thymic function. No routine checkup includes an immune aging panel. But the science connecting thymic involution to long-term health outcomes is substantial and growing rapidly. Researchers are actively investigating peptides and compounds that may support thymic regeneration, and the evidence base is advancing.

At The Lamkin Clinic, we take a comprehensive view of aging. Immune aging is part of how we think about healthspan because the research makes clear it should be. For patients who are serious about understanding their biological trajectory, immune function and inflammatory status are part of the conversation.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma

08/22/2026

A 2026 study published in The Lancet Obstetrics, Gynaecology, and Women's Health found that among postmenopausal women with obesity, combining hormone therapy with GLP-1 medication produced better metabolic outcomes than either intervention alone.

This finding aligns with something we see clinically every day at The Lamkin Clinic. Menopause and metabolic dysfunction are not separate conditions that happen to occur at the same time. They are biologically interconnected, and addressing them together produces results that addressing them in isolation cannot.

Here is why the combination works.

Estrogen decline changes how the body stores fat, particularly increasing visceral adiposity. It reduces insulin sensitivity. It accelerates muscle loss. It shifts the metabolic environment in a direction that makes weight management harder, not because of willpower, but because the hormonal signals that regulated metabolism have changed.

GLP-1 medications address part of this picture. They reduce appetite, improve insulin sensitivity, and support weight loss. But they do not address the hormonal environment that shifted the metabolic baseline in the first place.

When you combine hormone therapy with GLP-1 medication, you are addressing both sides of the equation simultaneously. The hormone therapy restores the metabolic environment to a more functional baseline. The GLP-1 medication works within that restored environment to produce better outcomes than it could in a hormonally depleted one.

This is the framework behind how we approach menopausal metabolic health at The Lamkin Clinic. We do not treat menopause as a reproductive event and weight gain as a lifestyle problem. We evaluate the hormonal picture, metabolic markers, body composition via DEXA, inflammatory load, and muscle status together, because that is how the biology actually works.

If you are navigating menopause and metabolic changes and have only been addressing one side of that equation, the combined approach is worth a serious conversation.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma

Protein needs after 40 are not the same as they were at 25.Anabolic resistance means muscle tissue responds less efficie...
08/20/2026

Protein needs after 40 are not the same as they were at 25.

Anabolic resistance means muscle tissue responds less efficiently to the same protein dose. At the same time, protecting lean mass becomes more important for blood sugar control, strength, recovery, and healthy aging.

In my work as a dietitian at The Lamkin Clinic, this is one of the most common adjustments we make. People are often under-protein relative to their goals, stacking most of their intake at dinner, or pairing a calorie deficit with almost no resistance training.

What tends to help:
- Enough total protein for age, body size, and activity
- Spreading protein across meals
- Strength training as part of the plan, not an optional add-on
- Using DEXA or other composition measures when we need a clearer picture than the scale

This is nutrition as metabolic care, not a temporary diet.

Deb Lamkin, RD/LD, CDE
The Lamkin Clinic | Edmond, Oklahoma
lamkinclinic.com

When people lose weight quickly, especially on GLP-1 medications, the goal is not only a lower number on the scale. The ...
08/19/2026

When people lose weight quickly, especially on GLP-1 medications, the goal is not only a lower number on the scale. The goal is better body composition: less fat, preserved or improved muscle.

Muscle is not cosmetic. It is a metabolic organ. It supports insulin sensitivity, resting energy expenditure, functional strength, and healthy aging. Lose too much of it, and the "success" on the scale can hide a weaker metabolic foundation.

At The Lamkin Clinic, we pair body composition goals with real measurement. DEXA shows fat mass, lean mass, and visceral fat in a way a bathroom scale never will. For patients who need additional support for muscle and fat reduction, Emsculpt NEO is available in our BTL Technology Center, Oklahoma's only BTL Academic Center. It combines HIFEM and radiofrequency to build muscle and reduce fat in treated areas as part of a broader clinical plan, not as a standalone gimmick.

If you are on a weight loss protocol, or planning one, ask what is happening to your muscle, not just your weight.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma
lamkinclinic.com

Forbes covered a major shift this week: peptides that have lived in a regulatory gray zone may be moving toward clearer ...
08/18/2026

Forbes covered a major shift this week: peptides that have lived in a regulatory gray zone may be moving toward clearer legal pathways, and companies are lining up to commercialize them.

That headline will create a wave of curiosity. It should also create a wave of caution.

Peptides are signaling molecules. Some, like insulin and GLP-1 medications, are well established pharmaceuticals. Others used in longevity and performance settings require clinical judgment, quality sourcing, appropriate patient selection, and ongoing monitoring. A checkout cart cannot replace that.

At The Lamkin Clinic, peptide therapy sits inside a full clinical model. Advanced labs, body composition, hormone status, metabolic health, and clear goals come first. Then we decide whether a peptide protocol is appropriate, which compound, and how to track response.

If you have been researching peptides because of recent news and want a physician-led conversation rather than a product pitch, we are here for that.

Request an appointment at lamkinclinic.com.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma
Oklahoma's only BTL Academic Center

08/17/2026

The Pentagon just mandated annual testosterone screening for all service members over 30. The stated objective: optimize performance and readiness.

This is a significant moment, not because of the politics surrounding it, but because of what it reflects clinically. Testosterone decline in men is not a slow, inevitable background condition to be tolerated. It is a measurable, treatable change that affects energy, body composition, cardiovascular health, bone density, cognitive function, and quality of life.

The problem is how infrequently this gets evaluated in civilian care. Most men first encounter the topic of testosterone from their physician when symptoms are already substantial. By that point, the decline has typically been progressing for years.

A full hormone evaluation includes more than total testosterone. Free testosterone, s*x hormone binding globulin, luteinizing hormone, follicle stimulating hormone, and estradiol all contribute to the complete picture. Without that full panel, it is easy to attribute a patient's fatigue, poor recovery, or mood changes to the wrong cause.

At The Lamkin Clinic, hormone optimization for men has been a core part of our practice for over 25 years. We have evaluated and worked with more than 1,500 patients using individualized protocols based on comprehensive lab work, symptoms, and body composition data, not population averages.

The conversation the military is now having about testosterone is one every man over 30 should be having with his physician.

If you have never had a full hormone panel, we are happy to start there.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma

08/14/2026

The FDA's Pharmacy Compounding Advisory Committee voted this week to recommend adding certain compounded peptides to the permitted list. The vote broke with the agency's own scientists, who had recommended against the move.

Here is what this means and what it does not mean.

What it means: the advisory committee recognized that physician-supervised compounded peptide therapy serves a legitimate clinical need. Their recommendation signals that appropriately sourced and prescribed peptides, produced by licensed compounding pharmacies under established quality standards, should remain accessible to patients who benefit from them.

What it does not mean: the recommendation is not a final rule. The FDA will review the committee's vote and make its own determination. The regulatory process will continue to unfold.

What has not changed at all: the clinical framework that makes peptide therapy work. A physician evaluation. Comprehensive labs. Individualized compound selection. Appropriate dosing. Ongoing monitoring. Follow-up and adjustment based on response. This is the infrastructure that separates a therapeutic protocol from a transaction.

At The Lamkin Clinic, we have always operated within that framework. We work exclusively with licensed compounding pharmacies. We follow regulatory developments closely and communicate with patients directly when anything affects their protocol.

The growing interest in peptide therapy is understandable. The science behind specific compounds is genuine. But the difference between a peptide protocol that produces results and one that creates risk is not the compound. It is the clinical model surrounding it.

If you have been following the regulatory news and have questions about how peptide therapy works in a physician-supervised setting, that conversation is one we are glad to have.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma
Oklahoma's only BTL Academic Center

08/13/2026

A study published this week in Diabetes Care found something that should shift how we evaluate metabolic risk: higher skeletal muscle mass is independently associated with a lower risk of developing type 2 diabetes, regardless of body weight or BMI.

That last part matters. The researchers found the protective association held even when controlling for obesity, age, and established cardiovascular risk factors. Lean muscle mass was its own independent variable.

Why does this matter clinically? Because the tools we use to screen for diabetes risk, fasting glucose, HbA1c, BMI, almost entirely miss this variable. Two patients can have identical blood sugar markers and identical body weight with dramatically different lean mass. The one with less muscle is at meaningfully higher metabolic risk. Standard screening will not reveal that difference.

Muscle is a metabolic organ. It is the primary site of glucose uptake after a meal, driven largely by GLUT4 transporters that activate through both insulin signaling and muscular contraction. When lean mass is low, glucose handling is impaired even when the standard labs look acceptable. This is one of the mechanisms behind why normal labs and poor metabolic function coexist so frequently in patients who know something is off.

At The Lamkin Clinic, we include DEXA body composition analysis in our metabolic workup. Not as a supplemental add-on, but because the body composition variables that predict metabolic risk simply are not visible without it. Total body weight tells you the sum. DEXA tells you what that sum is made of.

If your metabolic screening has never included a body composition scan, there is a real gap in the picture.

Brian Lamkin DO
The Lamkin Clinic | Edmond, Oklahoma

08/12/2026

A new study published this week is generating real discussion in metabolic medicine circles: a specific dietary pattern, high in polyphenols, fermented foods, and prebiotic fiber, is associated with measurably higher endogenous GLP-1 levels.

GLP-1 is the hormone that injectable medications like semaglutide mimic. The headline calling this "better than Ozempic" is an overreach. But the underlying finding is worth discussing seriously.

What the research shows is that the foods you eat can meaningfully influence how much of this hormone your body produces on its own. And the dietary pattern associated with higher endogenous GLP-1 is not exotic or difficult. It looks like this:

High fiber from diverse whole plant foods. Regular inclusion of fermented foods such as kefir, yogurt, kimchi, or sauerkraut. Minimizing ultra-processed carbohydrates and refined sugars. Adequate protein at every meal to support satiety and stable glucose.

This is not a case against GLP-1 medications for patients who need them. For many people with significant metabolic dysfunction, those medications are appropriate and clinically indicated. The point is that nutritional strategy matters alongside the medication, not instead of it.

At The Lamkin Clinic, when a patient begins GLP-1 therapy, we build a nutritional protocol around it from the start. How you eat during the medication course determines how much lean mass you preserve, how sustainable the results are, and what your metabolic health looks like long-term.

The medication creates a window. What you do with that window is a nutrition conversation.

Deb Lamkin, RD/LD, CDE
The Lamkin Clinic | Edmond, Oklahoma

Address

4001 East Covell Road, Ste. 100
Edmond, OK
73034

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm

Telephone

+14052854762

Website

,

Alerts

Be the first to know and let us send you an email when The Lamkin Clinic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category